跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
JARDIANCE empagliflozin 25 mg film-coated tablets blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
JARDIANCE empagliflozin 25 mg film-coated tablets blister pack
Approved
STANDARD
JARDIANCE empagliflozin 25 mg film-coated tablets blister pack
Boehringer Ingelheim Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
4b28b5c4af94a5cb
Company
Boehringer Ingelheim Pty Ltd
Type
Standard
Approval Details
Approval Id
4b28b5c4af94a5cb
Product Name
JARDIANCE empagliflozin 25 mg film-coated tablets blister pack
Artg Id
208827
Artg Name
JARDIANCE empagliflozin 25 mg film-coated tablets blister pack
Sponsor
Boehringer Ingelheim Pty Ltd
Company Detail Path
/organization/boehringer-ingelheim-pty-ltd
Artg Date
2014-04-30
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/a01742b9933218a6f3dc8521c0599c20.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/142b7f9a9af42a27772b909147fc272b.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
4b28b5c4af94a5cb
Type
Standard
Back to TGA Approvals